Imugene’s HER-Vaxx to be presented at US oncology meeting

Imugene’s HER-Vaxx to be presented at US oncology meeting

29 Apr 2019 - Immuno-oncology company Imugene (ASX:IMU) will present data from its Phase Ib study of its HER-Vaxx cancer vaccine at the prestigious American Society of Clinical Oncology (ASCO) annual meeting in Chicago Illinois in the US at the en...
Finance News Network